Ohio State Navbar

Research

Ongoing Studies


Ongoing Clinical Research Trials:
              
The Ohio State University Medical Center is a national leader in conducting clinical trials for prevention and treatment of various diseases, which includes diabetes. The Division of Endocrinology, Diabetes and Metabolism and the Diabetes Research Center conduct research for Type 1 and Type 2 diabetes both for NIH and industry sponsored studies.              

For information on the benefits and risks of participating in a clinical research trial, please click here.

The Division of Endocrinology, Diabetes and Metabolism and the DRC are currently enrolling in the following clinical trials. Each study has specific requirements for enrolment. If you are interested in participating in any of the studies, please contact the person listed.



1. PARADIGHM: This is a chronic hypoparathyroidism study. The patient must have hypopara for more than 6 months, and must be older than 18. The study involves data collection via IHIS, as well as 4 questionnaires the patient will fill out annually. The patient will receive 25$ everytime they fill these questionnaires out. I will follow them throughout the years collecting de-identified data.

For more information and to enroll, please contact Amber Anaya at <614-688-6257>.

 2. Emory: This is an inpatient Type 2 diabetes study. We are comparing Glargine and Sitagliptin, to a Basal Bolus regimen. The patient will be randomized to one of the two groups. The patient must be in the hospital at least  24 hours post consenting. There is an inpatient portion, as well as an outpatient portion. The study lasts about 6 months, including the inpatient portion, and 3 follow up visits. At each of these follow up visits (held at CarePoint East) they will be reimbursed 75$. Their diabetes will be managed by Dr. Dungan.

For more information and to enroll, please contact Kelly Rogers at <614-688-6885>.